Inquiry Basket
Fmoc-D-Arg(Me)2-OH (asymmetrical), a specialized amino acid derivative, finds key applications in peptide synthesis and pharmaceutical research. Explore its diverse utility with high perplexity and burstiness:
Peptide Synthesis: Delving into the realm of solid-phase peptide synthesis, Fmoc-D-Arg(Me)2-OH (asymmetrical) emerges as a pivotal tool for introducing arginine residues with tailored modifications. This modified arginine not only enhances the stability, solubility, and biological activity of peptides but also enables the creation of peptides with bespoke functionalities. Researchers harness this derivative to craft peptides that cater to specific biochemical studies and therapeutic endeavors, pushing the boundaries of peptide science.
Drug Development: In the landscape of pharmaceutical exploration, Fmoc-D-Arg(Me)2-OH (asymmetrical) plays a crucial role in the development of peptide-based drugs. Its unique composition allows for the incorporation of asymmetrical dimethyl-arginine, enhancing the interaction of peptides with biological targets. This enhancement paves the way for the design of more potent and selective therapeutic agents targeting conditions like cancer, infectious diseases, and metabolic disorders, ushering in a new era of precision medicine.
Protein Engineering: Embarking on the frontier of protein manipulation, Fmoc-D-Arg(Me)2-OH (asymmetrical) serves as a beacon for studying the impact of specific post-translational modifications on protein function. By integrating this modified amino acid into proteins, scientists can unravel the effects of arginine methylation on protein architecture, function, and interactions. This profound understanding of regulatory mechanisms not only enriches our knowledge but also facilitates the creation of proteins endowed with heightened or novel properties, heralding a new era of protein design.
Biomarker Discovery: Empowering the quest for novel biomarkers, Fmoc-D-Arg(Me)2-OH (asymmetrical) stands at the forefront of synthetic peptide development. Its application aids in the synthesis of modified peptides utilized as standards or probes in mass spectrometry-based assays to detect and quantify arginine methylation in biological samples. This innovative approach is pivotal in identifying disease-specific biomarkers, propelling forward the field of personalized medicine and diagnostic advancements.
